sur PolyPeptide Group
PolyPeptide appoints Chief Commercial Officer
PolyPeptide Group AG has announced the appointment of Stéphane Varray as Chief Commercial Officer, effective January 2025. Varray will also join the PolyPeptide Management Committee. This decision aligns with PolyPeptide's strategy to evolve its commercial capabilities as the peptide market grows, particularly due to GLP-1 therapies.
Stéphane Varray, a Swiss/French citizen, holds a PhD in Organic Chemistry from the University of Montpellier. He previously worked at Corden Pharma, overseeing the peptides platform, and spent nearly two decades with Lonza in various commercial and leadership roles.
Juan José González, CEO of PolyPeptide, expressed his excitement about Varray's appointment, citing his exceptional track record and leadership experience in the peptide industry. González believes Varray will be instrumental in strengthening PolyPeptide's commercial agenda as part of their growth strategy.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de PolyPeptide Group